LACOSTA SMITH: Open Payments
NPI 1053704403 · ALBANY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 14 payments from 10 companies in 2025. Trend: 2023 $358 · 2024 $123 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Exact Sciences Corporation | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NURTEC ODT, CAPLYTA, FANAPT, Auvelity, MOUNJARO, XIFAXAN, REXULTI, The Cologuard Plus Collection Kit.
Industry payments across KY — which companies pay providers there.
